The endogenous peptides of normal human serum extracted from the acetonitrile-insoluble precipitate using modified aqueous buffer with analysis by LC-ESI-Paul ion trap and Qq-TOF.
暂无分享,去创建一个
Monika Tucholska | John G Marshall | M. Tucholska | Declan Williams | Angelique Florentinus | Declan Williams | John G. Marshall | A. Florentinus
[1] W. Hancock,et al. Study of the human plasma proteome of rheumatoid arthritis. , 2009, Journal of chromatography. A.
[2] Paul Tempst,et al. Data analysis of assorted serum peptidome profiles , 2007, Nature Protocols.
[3] P. Højrup,et al. Rapid identification of proteins by peptide-mass fingerprinting , 1993, Current Biology.
[4] Richard D. Smith,et al. Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications* , 2006, Molecular & Cellular Proteomics.
[5] Alexey I Nesvizhskii,et al. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. , 2002, Analytical chemistry.
[6] Anita Saraf,et al. Reducing agent-mediated precipitation of high-abundance plasma proteins. , 2009, Analytical biochemistry.
[7] G. Stafford. Instrumental aspects of positive and negative ion chemical ionization mass spectrometry. , 1980, Environmental health perspectives.
[8] M. Fälth,et al. SwePep, a Database Designed for Endogenous Peptides and Mass Spectrometry* , 2006, Molecular & Cellular Proteomics.
[9] Sean L Seymour,et al. The Paragon Algorithm, a Next Generation Search Engine That Uses Sequence Temperature Values and Feature Probabilities to Identify Peptides from Tandem Mass Spectra*S , 2007, Molecular & Cellular Proteomics.
[10] G. Qian,et al. Inhibition of proliferation and apoptosis induced by a Na+/H+ exchanger-1 (NHE-1) antisense gene on drug-resistant human small cell lung cancer cells. , 2009, Oncology reports.
[11] T. Veenstra,et al. Enrichment of low-molecular-weight proteins from biofluids for biomarker discovery , 2005, Expert review of proteomics.
[12] Ronald J Moore,et al. Characterization of the human blood plasma proteome , 2005, Proteomics.
[13] K. Evans,et al. Endogenous peptides from biophysical and biochemical fractionation of serum analyzed by matrix-assisted laser desorption/ionization and electrospray ionization hybrid quadrupole time-of-flight. , 2007, Analytical biochemistry.
[14] P. Chueh,et al. Molecular cloning and characterization of a tumor-associated, growth-related, and time-keeping hydroquinone (NADH) oxidase (tNOX) of the HeLa cell surface. , 2002, Biochemistry.
[15] Christoph H Borchers,et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma , 2009, Nature Biotechnology.
[16] N. Seidah,et al. Annexin A2 Is a C-terminal PCSK9-binding Protein That Regulates Endogenous Low Density Lipoprotein Receptor Levels* , 2008, Journal of Biological Chemistry.
[17] D. Chan,et al. Identification of tumor‐associated plasma biomarkers using proteomic techniques: From mouse to human , 2004, Proteomics.
[18] V. Castronovo,et al. Low dentin matrix protein 1 expression correlates with skeletal metastases development in breast cancer patients and enhances cell migratory capacity in vitro , 2007, Breast Cancer Research and Treatment.
[19] M. Baker,et al. Evaluation of endogenous plasma peptide extraction methods for mass spectrometric biomarker discovery. , 2007, Journal of proteome research.
[20] P. Tempst,et al. A Sequence-specific Exopeptidase Activity Test (SSEAT) for “Functional” Biomarker Discovery*S , 2008, Molecular & Cellular Proteomics.
[21] E. Diamandis,et al. Comparison of protein expression lists from mass spectrometry of human blood fluids using exact peptide sequences versus BLAST , 2006, Clinical Proteomics.
[22] Weimin Zhu,et al. Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. , 2003, Journal of proteome research.
[23] Christoph Menzel,et al. Prerequisites for peptidomic analysis of blood samples: I. Evaluation of blood specimen qualities and determination of technical performance characteristics. , 2005, Combinatorial chemistry & high throughput screening.
[24] M. Schrader,et al. Detection of low-molecular-mass plasma peptides in the cavernous and systemic blood of healthy men during penile flaccidity and rigidity--an experimental approach using the novel differential peptide display technology. , 2002, Urology.
[25] J. G. Patton,et al. Cloning and characterization of PSF, a novel pre-mRNA splicing factor. , 1993, Genes & development.
[26] Ralph S Freedman,et al. Ovarian cancer, the coagulation pathway, and inflammation , 2005, Journal of Translational Medicine.
[27] H. Perreault,et al. Characterization of plasma proteins adsorbed onto biomaterials. By MALDI-TOFMS. , 2000, Biomaterials.
[28] E. Diamandis,et al. Comparison of methods to examine the endogenous peptides of fetal calf serum , 2006, Clinical Proteomics.
[29] R. Aebersold,et al. A statistical model for identifying proteins by tandem mass spectrometry. , 2003, Analytical chemistry.
[30] J. Nezu,et al. A novel family of bromodomain genes. , 2000, Genomics.
[31] Yanlei Ma,et al. Proteomics Identification of Desmin as a Potential Oncofetal Diagnostic and Prognostic Biomarker in Colorectal Cancer* , 2009, Molecular & Cellular Proteomics.
[32] T. Veenstra,et al. Characterization of the Low Molecular Weight Human Serum Proteome*S , 2003, Molecular & Cellular Proteomics.
[33] A. Nesvizhskii,et al. Experimental protein mixture for validating tandem mass spectral analysis. , 2002, Omics : a journal of integrative biology.
[34] I. Behrmann,et al. A cost effective non-commercial ECL-solution for Western blot detections yielding strong signals and low background. , 2007, Journal of immunological methods.
[35] Harald Tammen,et al. Specimen Collection and Handling , 2008 .
[36] S. Natsugoe,et al. Diagnostic value of serum peptidome analyses for protease activated pathological conditions beyond cancer diagnosis. , 2009, Medical hypotheses.
[37] P. Tempst,et al. Serum Peptidome Patterns That Distinguish Metastatic Thyroid Carcinoma from Cancer-free Controls Are Unbiased by Gender and Age*S , 2006, Molecular & Cellular Proteomics.
[38] C. Schaefer,et al. Analysis of the human serum proteome , 2004, Clinical Proteomics.
[39] Ching-Jin Chang,et al. Regulation of tristetraprolin during differentiation of 3T3‐L1 preadipocytes , 2007, The FEBS journal.
[40] P. Verhaert,et al. Matrix‐assisted laser desorption/ionization quadrupole Time‐of‐Flight Mass Spectrometry: An elegant tool for peptidomics , 2001, Proteomics.
[41] Balwir Matharoo-Ball,et al. Enrichment of low molecular weight serum proteins using acetonitrile precipitation for mass spectrometry based proteomic analysis. , 2008, Rapid communications in mass spectrometry : RCM.
[42] E. Petricoin,et al. Analysis of albumin-associated peptides and proteins from ovarian cancer patients. , 2005, Clinical chemistry.
[43] A. Olshen,et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. , 2005, The Journal of clinical investigation.
[44] J. Mymryk,et al. Roles for the coactivators CBP and p300 and the APC/C E3 ubiquitin ligase in E1A-dependent cell transformation , 2006, British Journal of Cancer.
[45] R. Beavis,et al. Tandem mass spectrometry of human tryptic blood peptides calculated by a statistical algorithm and captured by a relational database with exploration by a general statistical analysis system. , 2009, Journal of proteomics.
[46] Rency S Varghese,et al. Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma , 2006, Proteomics.
[47] H. Schägger,et al. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.
[48] H. Tammen,et al. Peptidomic analysis of blood plasma after in vivo treatment with protease inhibitors—A proof of concept study , 2008, Peptides.
[49] G. Jackowski,et al. Human serum proteins preseparated by electrophoresis or chromatography followed by tandem mass spectrometry. , 2004, Journal of proteome research.
[50] Makarov,et al. Electrostatic axially harmonic orbital trapping: a high-performance technique of mass analysis , 2000, Analytical chemistry.
[51] H. Towbin,et al. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[52] J. Barbosa,et al. Evaluation of on‐line solid phase extraction‐capillary electrophoresis‐electrospray‐mass spectrometry for the analysis of neuropeptides in human plasma , 2008, Electrophoresis.
[53] Daniel W. Chan,et al. Clinical proteomics , 2006 .
[54] E. Holland,et al. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. , 2004, Analytical chemistry.
[55] Ronald J. Moore,et al. Toward a Human Blood Serum Proteome , 2002, Molecular & Cellular Proteomics.
[56] Ying Wang,et al. The human plasma proteome: Analysis of Chinese serum using shotgun strategy , 2005, Proteomics.
[57] M. Tucholska,et al. Human serum proteins fractionated by preparative partition chromatography prior to LC-ESI-MS/MS. , 2009, Journal of proteome research.
[58] Robertson Craig,et al. TANDEM: matching proteins with tandem mass spectra. , 2004, Bioinformatics.
[59] C. V. Jongeneel,et al. Identification of cancer/testis-antigen genes by massively parallel signature sequencing , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[60] H. Zou,et al. Selective extraction of peptides in acidic human plasma by porous silica nanoparticles for peptidome analysis with 2-D LC-MS/MS. , 2007, Journal of separation science.
[61] A. Shevchenko,et al. Rapid 'de novo' peptide sequencing by a combination of nanoelectrospray, isotopic labeling and a quadrupole/time-of-flight mass spectrometer. , 1997, Rapid communications in mass spectrometry : RCM.
[62] Eugene A. Kapp,et al. Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database , 2005, Proteomics.
[63] P. Budde,et al. Peptidomics analysis of human blood specimens for biomarker discovery , 2007, Expert review of molecular diagnostics.
[64] G. Hortin. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. , 2006, Clinical chemistry.
[65] J. Yates,et al. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. , 1995, Analytical chemistry.
[66] T. Veenstra,et al. Organic solvent extraction of proteins and peptides from serum as an effective sample preparation for detection and identification of biomarkers by mass spectrometry , 2004, Proteomics.
[67] G. Woude,et al. An alternatively spliced form of Met receptor is tumorigenic , 2006, Experimental & Molecular Medicine.
[68] M. Jones,et al. Identification and characterization of BPTF, a novel bromodomain transcription factor. , 2000, Genomics.
[69] William E Grizzle,et al. Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[70] M. Schrader,et al. Composition of the peptide fraction in human blood plasma: database of circulating human peptides. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[71] T. Colgan,et al. Protein expression profiling of endometrial malignancies reveals a new tumor marker: chaperonin 10. , 2004, Journal of proteome research.
[72] David M. Conrad,et al. Ryanodine receptor signaling is required for anti‐CD3‐induced T cell proliferation, interleukin‐2 synthesis, and interleukin‐2 receptor signaling , 2004, Journal of cellular biochemistry.
[73] K. Coombes,et al. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. , 2005, Journal of proteome research.
[74] T. McCarthy,et al. Activation of ryanodine receptor/Ca2+ release channels downregulates CD38 in the Namalwa B lymphoma , 2003, FEBS letters.
[75] Michael R. Green,et al. p53-Mediated Inhibition of Angiogenesis Through Up-Regulation of a Collagen Prolyl Hydroxylase , 2006, Science.
[76] H. Tammen,et al. Peptidomic analysis of human blood specimens: Comparison between plasma specimens and serum by differential peptide display , 2005, Proteomics.
[77] David A Bennett,et al. High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures. , 2005, Clinical chemistry.
[78] D. N. Perkins,et al. Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.
[79] Xueyun Chen,et al. Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers. , 2009, Oncology reports.
[80] E. Petricoin,et al. An investigation into the human serum “interactome” , 2004, Electrophoresis.
[81] S. Hanash,et al. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study , 2006, Nature Biotechnology.
[82] Mingliang Ye,et al. Selective on-line serum peptide extraction and multidimensional separation by coupling a restricted-access material-based capillary trap column with nanoliquid chromatography-tandem mass spectrometry. , 2009, Journal of chromatography. A.
[83] Bob Löwenberg,et al. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. , 2003, Blood.
[84] W. Hancock,et al. Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer. , 2006, Journal of chromatography. A.
[85] David Fenyö,et al. Validation of endogenous peptide identifications using a database of tandem mass spectra. , 2008, Journal of proteome research.
[86] I. Shih,et al. Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal Mesothelioma , 2006, Clinical Cancer Research.
[87] Rong Zeng,et al. Human plasma proteome analysis by multidimensional chromatography prefractionation and linear ion trap mass spectrometry identification. , 2005, Journal of proteome research.
[88] G. Hortin,et al. Diverse range of small peptides associated with high-density lipoprotein. , 2006, Biochemical and biophysical research communications.
[89] Ronald J Moore,et al. Ultra-high-efficiency strong cation exchange LC/RPLC/MS/MS for high dynamic range characterization of the human plasma proteome. , 2004, Analytical chemistry.
[90] J. Jonklaas,et al. Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer. , 2008, Thyroid : official journal of the American Thyroid Association.
[91] B. Cargile,et al. Potential for false positive identifications from large databases through tandem mass spectrometry. , 2004, Journal of proteome research.
[92] F. Fernández,et al. Serum biomarker profiling by solid-phase extraction with particle-embedded micro tips and matrix-assisted laser desorption/ionization mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.
[93] Gilbert S Omenn,et al. An evaluation, comparison, and accurate benchmarking of several publicly available MS/MS search algorithms: Sensitivity and specificity analysis , 2005, Proteomics.